STOCKHOLDERS DEFICIT (Details) - Warrant [Member] - $ / shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Warrants outstanding, beginning balance | 45,165,649 | 37,174,468 |
| Warrants issued | 7,177,500 | 2,656,023 |
| Warrants exchanged | (4,825,000) | |
| Warrants expired | (900,000) | |
| Warrants exercised | (4,825,000) | |
| Warrants outstanding, ending balance | 41,793,149 | 39,830,491 |
| Weighted average exercise price per share, beginning balance | $ 0.40 | $ 0.42 |
| Weighted average exercise price per share, warrants issued | 0.22 | 0.13 |
| Weighted average exercise price per share, warrants exchanged | 0.51 | |
| Weighted average exercise price per share, warrants expired | 0.30 | |
| Weighted average exercise price per share, warrants exercised | 0.20 | |
| Weighted average exercise price per share, ending balance | $ 0.38 | $ 0.40 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Other increase (decrease) in number of shares reserved for issuance under non-option equity instrument agreements that is not separately disclosed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|